IPO

#Healthin2Point00, Episode 232 | Cue Health goes public + funding for Stellar, eVisit, & Neuroglee

Today on Health in 2 Point 00, Jess and I are at UCSF – we’ll be providing color commentary for the UCSF Health Awards, so tune in tonight for that. On Episode 232, Jess asks me about more deals including Stellar Health raising $60 million, Cue Health going public (and stealing the HLTH ticket), and …

#Healthin2Point00, Episode 232 | Cue Health goes public + funding for Stellar, eVisit, & Neuroglee Read More »

AI specialist Exscientia raises $510m in upsized IPO, placing

Exscientia’s artificial intelligence-based drug discovery engine is still largely unproven, but that hasn’t stopped the company raking in funding from investors keen to back its platform. The final numbers are now in from its recently announced initial public offering on the US Nasdaq, and the numbers are impressive, swelling from an initially forecast $304 million …

AI specialist Exscientia raises $510m in upsized IPO, placing Read More »

Oxford Nanopore makes stellar debut on UK stock market

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards the £5 billion ($6.7 billion) mark. The Oxford University spinout saw its share price rise from an opening of 425p to 612p by close of trading …

Oxford Nanopore makes stellar debut on UK stock market Read More »

With 5 patents under its belt, RCM tech company Ensemble Health Partners files for IPO

The company, which provides revenue cycle management solutions for providers, is filing for the IPO less than two years after Bon Secours Mercy Health sold its majority stake in Ensemble to private equity firm Golden Gate Capital. Per the filing, the company aims to raise $100 million, but that is likely a placeholder figure.

Sharecare ($SHCR) Hits NASDAQ Tomorrow, CEO Jeff Arnold on Closing the SPAC IPO

By JESSICA DaMASSA, WTF HEALTH Sharecare ($SHCR) starts trading on the NASDAQ tomorrow and CEO Jeff Arnold has come back to catch us up on what’s happened since April when we first spoke and took a deep-dive into Sharecare’s population-health-slash-care-navigator-slash-health-security business model. That interview (watch here: https://youtu.be/P6DzFbtiLWg) digs into the $400 million/year revenue model Jeff’s …

Sharecare ($SHCR) Hits NASDAQ Tomorrow, CEO Jeff Arnold on Closing the SPAC IPO Read More »

Ambrx tries another IPO as it chases down HER2 rivals

California biotech Ambrx Biopharma is hoping to raise $126 million from a listing on the New York Stock Exchange (NYSE) that will be used in part to fund clinical development of ARX-788, its HER2-targeting antibody drug conjugate (ADC). The Scripps Research spinout could be just 18 months away from licensee NovoCodex reporting results of a …

Ambrx tries another IPO as it chases down HER2 rivals Read More »

Arecor heads for London Stock Exchange with drug reformulation strategy

Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed drugs reformulated to provide extra benefits for patients.  Arecor Therapeutics is the latest company aiming to take advantage of the “feelgood” factor in the biotech sector, which …

Arecor heads for London Stock Exchange with drug reformulation strategy Read More »

Bright Health follows rival Oscar Health down IPO path

Bright Health has filed preliminary paperwork for an IPO, joining its rivals in the insurance technology space in going public. Though there are few confirmed details at the moment, Bright Health is reportedly looking to raise $1 billion through the offering.

Wall Street is lukewarm to Vera’s pivot from gene editing to rare kidney disease

Vera Therapeutics raised $47.9 million from its IPO to continue clinical development of its lead asset, a potential treatment for the kidney disease IgA nephropathy. But the company is joining a crowded field of companies aiming to develop a drug for the rare disorder.

#Healthin2Point00, Episode 203 | Privia goes public, Vocera acquires PatientSafe Solutions & more

Today on Health in 2 Point 00, Jess hardly knows the value of $100 million anymore – is it a salary, is it an entire fund, is it one single round? On Episode 203, Jess and I cover Vocera buying PatientSafe Solutions and Privia going public with a $3.7 billion market cap. Cash-paid healthcare services …

#Healthin2Point00, Episode 203 | Privia goes public, Vocera acquires PatientSafe Solutions & more Read More »

Privia Health launches IPO, aims to raise up to $370M

The physician practice management company launched its IPO through which it plans to sell 19.5 million shares of common stock, priced between $17 and $19 per share. It will use the proceeds for general corporate purposes, like research and development, and to acquire complementary businesses or technologies.

Sharecare’s SPAC IPO: A Second Success for WebMD Founder Jeff Arnold?

By JESSICA DaMASSA, WTF HEALTH Sharecare, the population-health-slash-care-navigator of the stars (literally, celebrity doc Dr. Oz is a co-founder, and Oprah’s Harpo Productions, Sony Pictures Television, and Discovery Communications are partners) is about to hit the public market via a $4-Billion SPAC IPO with Falcon Capital. Jeff Arnold, co-founder, CEO, and Chairman drops in to …

Sharecare’s SPAC IPO: A Second Success for WebMD Founder Jeff Arnold? Read More »

Centessa plans $100m IPO to fund R&D and potential acquisitions

Centessa has announced plans for a $100m US IPO just weeks after the company launched with $250m in private backing and an R&D powerhouse driven by the merger of 10 biotechs. In a filing with the Securities and Exchange Commission, Centessa said it plans to use proceeds to fund the development of the 16 drugs …

Centessa plans $100m IPO to fund R&D and potential acquisitions Read More »

Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform

– Today Benchling, the leading life and sciences R&D cloud, announced a $200M Series E raise led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital, and Elad Gil. This funding will be used to aggressively invest in product development and global expansion to support enterprise customers. The raise is also joined …

Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform Read More »

Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity

The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response.  Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated.  Over the course of the quarter, we observed $7 billion in private …

Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity Read More »

Cancer Research UK spinout Achilles raises $175.5m in IPO

UK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US, raising $175.5 million that will be used to take its personalised T cell therapy for lung and skin cancers through proof-of-concept trials. The new funding will also be used to advance two more T cell programmes for head and neck and …

Cancer Research UK spinout Achilles raises $175.5m in IPO Read More »

Report: Bright Health eyes $1B IPO

Insurance startup Bright Health is reportedly planning to raise up to $1 billion in an IPO that will be launched in the second quarter of 2021. The company, which provides several insurance products as well as an IT platform, could be valued at more than $10 billion, Bloomberg reported.

Inside Owlet’s SPAC IPO: From Smart Sock Baby Monitor to Data-Driven Pediatric Healthcare Co

By JESSICA DaMASSA, WTF HEALTH Oh Baby! Connected digital nursery startup, Owlet Baby Care, just announced their SPAC IPO and intention to take their infant smart sock from baby monitor to FDA-approved medical device. I talk with Owlet’s co-founder & CEO, Kurt Workman, to find out why the baby health tech company (which has raised …

Inside Owlet’s SPAC IPO: From Smart Sock Baby Monitor to Data-Driven Pediatric Healthcare Co Read More »

Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation

What You Should Know: – Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. – The transaction is expected to be funded through a combination of Falcon’s $345 …

Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation Read More »

Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B

What You Should Know: – Shares of Signify Health, a value-based care billing platform for in-home and bundled health services jumped more than 33% in its initial public offering (IPO), valuing the company at over $7.12B. – Today, Signify Health’s CEO Kyle Armbrester will also join the ranks among the youngest CEOs to ever take …

Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B Read More »

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others

Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman of the Board of WBA. Brewer, 58, will become the …

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others Read More »

SPAC Compute Health Acquisition Prices $750M IPO, Led by Intel Chairman

Compute Health Acquisition Corp Chairman Omar Ishrak What You Should Know: – Compute Health Acquisition, a SPAC company targeting the intersection of computation and healthcare announced the pricing of its $750M initial public offering (IPO) by offering 75 million units at $10.  Compute Health Acquisition Corp. (the “Company”), a SPAC “blank check” company announced today …

SPAC Compute Health Acquisition Prices $750M IPO, Led by Intel Chairman Read More »

Casana Raises $14M to Expand IoT Heart Health Toilet Seat

What You Should Know: – Casana raises $14M in Series A funding to pursue FDA clearance for its an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output. Casana, previously known as Heart Health Intelligence, Inc., a healthcare technology firm that is re-inventing in-home …

Casana Raises $14M to Expand IoT Heart Health Toilet Seat Read More »

UK biotech investment at record levels amid COVID-19

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in …

UK biotech investment at record levels amid COVID-19 Read More »

AI drug discovery biotech AbCellera eyes record IPO

AbCellera Biologics has been in the spotlight since coming up with Eli Lilly’s COVID-19 antibody drug bamlanivimab, and looks set to capitalise on that exposure with a sizeable initial public offering. The Vancouver, Canada-headquartered biotech – which has been bankrolled in part by billionaire entrepreneur and venture capitalist Peter Thiel – plans to offer 23 …

AI drug discovery biotech AbCellera eyes record IPO Read More »

Israeli Digital Health Startup G Medical Innovations Withdraws $30M US IPO

What You Should Know: – Israeli-based G Medical Innovation has withdrawn its plans for an initial public offering (IPO) on Tuesday, Nasdaq first reports. – The company originally filed an IPO to raise $30 million by offering 5 million shares at a price range of $5 to $7 last month to list on the Nasdaq …

Israeli Digital Health Startup G Medical Innovations Withdraws $30M US IPO Read More »

Accolade’s CEO Raj Singh: IPO Backstory & Pop Health Predictions for 2021

By JESSICA DaMASSA, WTF HEALTH When Accolade went public in July at a $1.2B valuation, the BIG question facing the health tech unicorn pre-dated the covid-19 pandemic and the chaos facing its clientbase of large, self-insured employers: Could they scale? Raj Singh, Accolade’s CEO, tackles the question head-on, buoyed by customer growth that has doubled …

Accolade’s CEO Raj Singh: IPO Backstory & Pop Health Predictions for 2021 Read More »

#Healthin2Point00, Episode 157 | The phrase is “Takeout Speculation”!

Today on Health in 2 Point 00, Jess and I gossip about the wild rumor that UnitedHealthcare is acquiring Amwell. On Episode 157, we discuss Lark raising $55 million in a Series C along with a deal with Anthem to be their preferred DPP provider, Medicare Advantage plan Clover going public with a valuation of …

#Healthin2Point00, Episode 157 | The phrase is “Takeout Speculation”! Read More »

Analysis: July Health IT M&A Activity; Public Company Performance

– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020. While a pandemic ravages the country, technology valuations are soaring.  The Nasdaq hit an all-time high during the month of July, sailing through the 10,000 mark to post YTD gains …

Analysis: July Health IT M&A Activity; Public Company Performance Read More »

M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical

What You Should Know: – Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. – Deal expected to close in 1H 2021. – Varian Medical will maintain its brand name and operate “independently” – Siemens AG will drop holding in Siemens Healthineers from 85% to 72% as …

M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical Read More »

Primary care startup Oak Street Health goes public for $328M

Oak Street Health, which operates primary care centers for Medicare patients, went public on Thursday for $328 million. Its capitation payment model has helped the company continue on where many clinics have struggled during the Covid-19 pandemic.

Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug

US biotech Inozyme Pharma is the latest to jump on to the IPO bandwagon, setting terms for a $75 million stock market launch, as the firm gears up for clinical trials of its lead drug for rare bone diseases. Based in Boston, Massachusetts, the company plans to raise $75 million by offering 5 million shares …

Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug Read More »

HGP Semi-Annual Health IT Market Review: 6 Key Trends to Know

Healthcare Growth Partners, an Investment Banking and Strategic Advisory firm exclusively focused on the transformational health IT market, today announced the release of its Semi-Annual Health IT Market Review report that summarizes M&A and private equity activity across health IT, health information services, and digital health. Report Background/Methodology This edition of the report includes feedback from …

HGP Semi-Annual Health IT Market Review: 6 Key Trends to Know Read More »

Health in 2 Point 00, Episode 132 | Accolade IPO, Somatus, NexHealth, Tatch & more

Today on Health in 2 Point 00, Jess and I cover some big news! Accolade has filed its IPO, so on Episode 132 I give my take on this health care navigation service. We also cover Somatus getting $64 million for chronic kidney disease care, NexHealth raising $15 million, Tatch raising $4.25 million for sleep …

Health in 2 Point 00, Episode 132 | Accolade IPO, Somatus, NexHealth, Tatch & more

Read More »